Vivoryon Therapeutics N.V. Stock
Stocks
VVY
NL00150002Q7
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Euronext Amsterdam
20:55:00 10/11/2026 +04
|
After hours 00:27:04 | |||
| 0.6880 EUR | +4.88% |
|
0.7110 | +3.34% |
| 08-07 | Vivoryon Therapeutics N.V., H1 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Vivoryon Therapeutics N.V. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 19.43M 21.66M 17.9M 16.26M 30.77M 2.03B 31.63M 214M 85.41M 1.09B 81.3M 79.57M 3.44B | P/E 2026 * |
-1.73x | P/E 2027 * | -1.77x |
|---|---|---|---|---|---|
| Enterprise Value | 23.75M 26.48M 21.89M 19.88M 37.62M 2.48B 38.67M 262M 104M 1.33B 99.38M 97.27M 4.2B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
95.15% | Yield 2026 * |
-
| Yield 2027 * | - |
Euronext AmsterdamEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Amsterdam
| VVY | Real-time | |
Tradegate
| 05Y | Real-time | |
|
CBOE
| VVY | Real-time | |
|
Deutsche Boerse AG
| 05Y | Delayed | |
|
CBOE
| 0R3M | Real-time | |
|
Boerse Muenchen
| 05Y | Real-time | |
|
Börse Stuttgart
| 05Y | Delayed | |
|
Wiener Boerse
| VVYN | End-of-day quote |
Last Transcript: Vivoryon Therapeutics N.V.
| 1 day | +4.88% | ||
| 1 week | -11.79% | ||
| Current month | -14.21% | ||
| 1 month | -33.85% | ||
| 3 months | -40.17% | ||
| 6 months | -44.07% | ||
| Current year | -51.55% |
| 1 week | 0.52 |  | 0.91 |
| 1 month | 0.52 | | 1.07 |
| Current year | 0.52 | | 1.65 |
| 1 year | 0.52 | | 1.65 |
| 3 years | 0.41 | | 9.93 |
| 5 years | 0.41 | | 20.64 |
| 10 years | 0.41 | | 23.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frank Weber
CEO | Chief Executive Officer | 66 | 14/08/2023 |
Marcus Irsfeld
DFI | Director of Finance/CFO | - | 01/12/2025 |
Julia Neugebauer
COO | Chief Operating Officer | - | 01/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 56 | 01/01/2007 | |
Frank Weber
BRD | Director/Board Member | 66 | 15/09/2023 |
| Director/Board Member | 58 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/10/25 | Free | Chief Operating Officer | 20,000 | 0.0767% | ||
| 23/10/25 | Buy | Chief Executive Officer | 135,000 | 0.5179% | ||
| 23/10/25 | Free | 20,000 | 0.0767% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.88% | -11.79% | -58.25% | -90.72% | 21.76M | |
| +0.01% | +8.40% | +58.48% | +69.01% | 68.22B | |
| +1.22% | +9.56% | +15.97% | +90.23% | 59.82B | |
| +0.24% | +1.35% | +23.78% | +97.55% | 56.07B | |
| +1.16% | +19.05% | +28.37% | +112.25% | 47.67B | |
| -1.24% | +4.89% | +29.28% | +40.54% | 45.95B | |
| -4.13% | -1.70% | +204.36% | +868.67% | 43.29B | |
| -3.33% | +5.73% | +23.28% | +47.32% | 35.66B | |
| -2.19% | -3.71% | +90.94% | +66.33% | 34.73B | |
| +1.65% | +13.54% | -38.21% | +399.31% | 25.47B | |
| Average | -0.22% | +3.22% | +37.80% | +170.05% | 42B | |
| Weighted average by Cap. | -0.65% | +5.40% | +49.98% | +178.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -10.4M -11.6M -9.58M -8.7M -16.47M -1.09B -16.93M -115M -45.72M -583M -43.52M -42.6M -1.84B | -10.4M -11.6M -9.58M -8.7M -16.47M -1.09B -16.93M -115M -45.72M -583M -43.52M -42.6M -1.84B |
| Net Debt | 4.32M 4.82M 3.98M 3.62M 6.84M 452M 7.03M 47.67M 18.99M 242M 18.08M 17.69M 765M | 13.03M 14.53M 12.01M 10.91M 20.64M 1.36B 21.22M 144M 57.29M 730M 54.53M 53.37M 2.31B |
Employees
13
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/11/26 | €0.6880 | +4.88% | 92,564 |
| 09/11/26 | €0.6560 | +6.15% | 121,329 |
| 06/11/26 | €0.6180 | +11.55% | 342,016 |
| 05/11/26 | €0.5540 | -39.12% | 703,819 |
| 04/11/26 | €0.9100 | +16.67% | 149,028 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6560EUR
Average target price
6.850EUR
Spread / Average Target
+944.21%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VVY Stock
Select your edition
All financial news and data tailored to specific country editions
